![Teri Toth](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Teri Toth
Geen lopende functies
Profiel
Teri Toth worked as a Quality Director at MaxCyte, Inc., Director-Quality Systems at Cylex, Inc., Principal at Qiagen, Inc., and Principal at Dexall Biomedical Labs, Inc. She obtained an undergraduate degree from Bridgewater College.
Eerdere bekende functies van Teri Toth
Bedrijven | Functie | Einde |
---|---|---|
Cylex, Inc.
![]() Cylex, Inc. Medical SpecialtiesHealth Technology Cylex is a privately held global life science company that is in the development and manufacture of in vitrodiagnostic products. ImmuKnow is the in vitro diagnostic utilized to detect cell-mediated immunity (CMI) in an immunosuppressed population and is increasingly being adopted at organ transplant centers throughout the United States and abroad. The Company's patented technology provides a platform allowing clinical researchers to simply and reproducibly measure CMI for the development of new diagnostics, biomarkers and companion assays. The company is based in Columbia, MD and was founded in 1992 | Corporate Officer/Principal | 18-11-2013 |
Dexall Biomedical Labs, Inc. | Corporate Officer/Principal | - |
MAXCYTE, INC. | Corporate Officer/Principal | - |
Qiagen, Inc.
![]() Qiagen, Inc. Miscellaneous Commercial ServicesCommercial Services Qiagen, Inc. provided technologies for separating, purifying and handling nucleic acids. The company was founded in 1988 and was headquartered in Germantown, MD. | Corporate Officer/Principal | - |
Opleiding van Teri Toth
Bridgewater College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
MAXCYTE, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Cylex, Inc.
![]() Cylex, Inc. Medical SpecialtiesHealth Technology Cylex is a privately held global life science company that is in the development and manufacture of in vitrodiagnostic products. ImmuKnow is the in vitro diagnostic utilized to detect cell-mediated immunity (CMI) in an immunosuppressed population and is increasingly being adopted at organ transplant centers throughout the United States and abroad. The Company's patented technology provides a platform allowing clinical researchers to simply and reproducibly measure CMI for the development of new diagnostics, biomarkers and companion assays. The company is based in Columbia, MD and was founded in 1992 | Health Technology |
Qiagen, Inc.
![]() Qiagen, Inc. Miscellaneous Commercial ServicesCommercial Services Qiagen, Inc. provided technologies for separating, purifying and handling nucleic acids. The company was founded in 1988 and was headquartered in Germantown, MD. | Commercial Services |
Dexall Biomedical Labs, Inc. |